Cargando…
Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence
Elderly persons with currently normal cognition who have cerebral hypometabolism as shown by low uptake of (18)fluorine‐fluorodeoxyglucose ((18)F‐FDG), are at risk of future loss of cognition and, thus, of future Alzheimer's dementia (AD). Reduction of either (18)F‐FDG or cognition is assumed t...
Autor principal: | Fessel, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129845/ https://www.ncbi.nlm.nih.gov/pubmed/34027027 http://dx.doi.org/10.1002/trc2.12177 |
Ejemplares similares
-
A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons
por: Fessel, Jeffrey
Publicado: (2021) -
Synaptic mechanisms of cadmium neurotoxicity
por: Tsentsevitsky, Andrei N., et al.
Publicado: (2021) -
Fluid Biomarkers for Synaptic Dysfunction and Loss
por: Camporesi, Elena, et al.
Publicado: (2020) -
The role of GRP81 lactate receptor in synaptic transmission regulation: does it enhance endocytosis?
por: Fedorovich, Sergei V., et al.
Publicado: (2022) -
The potential for one drug, administered at the earliest preclinical stage, to prevent the subsequent decline of cognition that eventuates in dementia
por: Fessel, Jeffrey
Publicado: (2020)